Table 1.
Intervention | Aim | (Side-)effect on immunity | References |
---|---|---|---|
Oral contraceptives | Prevent ovulation | Increased risk for genital tract infections No effect on risk for MS, RA, SLE |
Fichorova et al. (2015), Mohllajee et al. (2006), Murphy et al. (2014), and Straub (2007) |
In vitro fertilization | Induce ovulation, maintain early pregnancy | Unknown | Huang and Rosenwaks (2012) and Yanushpolsky (2015) |
Estrogen replacement therapy | Alleviate peri- and postmenopausal symptoms | Partial restoration of immunological function seen during reproductive age Increased symptoms of SLE |
Holroyd and Edwards (2009), Giefing-Kroll et al. (2015), and Straub (2007) |
Aromatase inhibitors | Deprive ER+ breast cancer from estrogens | Clinical signs of RA (e.g., joint pain) | Zhang et al. (2010) |
Androgen replacement therapy | Reduction of inflammation in hypogonadism | Suppression of cellular and humoral immune responses | Cutolo et al. (2002), Kocar et al. (2000), Musabak et al. (2003), Ackerman (2006), Malkin et al. (2004), and Fijak et al. (2011) |
CRH antagonists | Reduction of excessive glucocorticoid release | Reduction of downstream immune-suppression | Elenkov et al. (1999) and Zoumakis et al. (2006) |
MS, multiple sclerosis; ER; estrogen receptor; RA; rheumatoid arthritis; SLE, systemic lupus erythematosus; CRH, corticotropin-releasing hormone.